| TOP STORY | Self-Renewal of Embryonic-Stem-Cell-Derived Progenitors by Organ-Matched Mesenchyme Researchers demonstrated that co-culture with organ-matched mesenchyme permits proliferation and self-renewal of progenitors, without differentiation, and enables an expansion of more than a million-fold for human endodermal cells with full retention of their developmental potential. This effect is specific both to the mesenchymal cell and to the progenitor being amplified. [Nature] Abstract |
| INDUSTRY NEWS | The Nobel Prize in Physiology or Medicine 2012: Sir John B. Gurdon, Shinya Yamanaka Nobel Assembly at Karolinska Institutet has decided to award The Nobel Prize in Physiology or Medicine 2012 jointly to John B. Gurdon and Shinya Yamanaka for the discovery that mature cells can be reprogrammed to become pluripotent. [Nobel Media AB] Press Release FDA Approves Stemedica Phase II Clinical Trial for Acute Myocardial Infarction with Ischemia Tolerant Mesenchymal Stem Cells Stemedica Cell Technologies, Inc. announced that the U.S. Food and Drug Administration approved its application for an Investigational New Drug to assess the clinical effects of Stemedyne-MSC (Stemedica’s human bone marrow-derived ischemia tolerant mesenchymal cells) in subjects with a myocardial infarction. [Stemedica Cell Technologies, Inc.] Press Release Osiris Therapeutics Regains Worldwide Rights to Prochymal and Chondrogen Osiris Therapeutics, Inc. announced the conclusion of its collaboration with Genzyme, a Sanofi company. Prochymal is a mesenchymal stem cell therapy indicated for the treatment of acute graft-vs-host disease in children. [Osiris Therapeutics, Inc.] Press Release SkelRegen Aims to Regenerate Skeletal Tissue A new approach to musculoskeletal care appears to be on the horizon with the recent formation of a company aiming to regenerate human bone and other skeletal tissue. The company, called SkelRegen, LLC (short for Skeletal Regeneration), has already identified several compounds that it believes could transform musculoskeletal care. [SkelRegen, LLC] Press Release |
| EVENTS | NEW Biobanking 2013 February 27, 2013 London, United Kingdom Visit our events page to see a complete list of events in the mesenchymal cell community. |
|
|
|